Rational Design of Dual-Targeted Nanomedicines for Enhanced Vascular Permeability in Low-Permeability Tumors
ACS Nano · 2025
DOI: 10.1021/acsnano.4c12808 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Mingsheng Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Capillary Permeability, Nanomedicine, Ferritins, Colonic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, National Postdoctoral Researcher Program of China.
Abstract (Originalsprache)
Designing dual-targeted nanomedicines to enhance tumor delivery efficacy is a complex challenge, largely due to the barrier posed by blood vessels during systemic delivery. Effective transport across endothelial cells is, therefore, a critical topic of study. Herein, we present a synthetic biology-based approach to engineer dual-targeted ferritin nanocages (Dt-FTn) for understanding receptor-mediated transport across tumor endothelial cells. By leveraging a genetically engineered logic-gated strategy, we coassembled various Dt-FTn in E. coli with tunable ratios of RGD-targeting and intrinsic TfR1-targeting ligands. These Dt-FTn constructs were employed to investigate the interaction between receptor-mediated vascular permeability and dual-targeted nanomedicines in low-permeability tumors. Through machine learning-based single vessel analysis, we uncovered the crucial role of dual-receptor expression profiles in determining the vascular transport of dual-targeted nanomedicines in tumors with low permeability. Using a patient-derived colon cancer model, we demonstrated a proof-of-concept that the optimal proportions of dual ligands in these nanomedicines can be customized based on tumor cell receptor expression profiles. This study provides valuable insights and guiding principles for the rational design of dual-targeted nanomedicines for tumor-targeted delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin 300071, China.
- Key Laboratory of Bioactive Materials for the Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China.
- State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300071, China.
- Frontier of Science Center for Cell Response, College of Life Sciences, Nankai University, Tianjin 300071, China.
- Changwu County People's Hospital, Changwu 713699, China.
ORCID-Profile: Xinglu Huang, Jie Zhuang
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- National Postdoctoral Researcher Program of China
- Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
Zitieren
APA
Zhu, M., Liu, Q., Chen, Z., Liu, J., Zhang, Z., Tian, J., Wang, X., Yang, X., Chen, Q., Huang, X., & Zhuang, J. (2025). Rational Design of Dual-Targeted Nanomedicines for Enhanced Vascular Permeability in Low-Permeability Tumors. ACS Nano. https://doi.org/10.1021/acsnano.4c12808
Vancouver
Zhu M, Liu Q, Chen Z, Liu J, Zhang Z, Tian J, et al. Rational Design of Dual-Targeted Nanomedicines for Enhanced Vascular Permeability in Low-Permeability Tumors. ACS Nano. 2025. doi:10.1021/acsnano.4c12808
BibTeX
@article{Zhu2025,
author = {Zhu, Mingsheng and Liu, Qiqi and Chen, Zhengbang and Liu, Jinming and Zhang, Zhixuan and Tian, Jingwei and Wang, Xiangyang and Yang, Xiong and Chen, Quan and Huang, Xinglu and Zhuang, Jie},
title = {Rational Design of Dual-Targeted Nanomedicines for Enhanced Vascular Permeability in Low-Permeability Tumors},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.4c12808}
}
EUVIMED